Daryl Pritchard, PhD
Vice President, Science Policy, Personalized Medicine CoalitionAuthored Items
April 2017 Vol 8, No 4
The FDA’s new personalized medicine approvals and expanded indications reflect the extraordinary pace of scientific innovation in the field.
Last modified: June 6, 2018